SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'A5A'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HMA_A_SAMA375_0 (PROBABLE TRNA (5-METHYLAMINOMETHYL -2-THIOURIDYLATE)-ME THYLTRANSFERASE)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	5 / 11	GLY A 299 THR A 138 GLY A 139 HIS A 141 PHE A 145	None None None A5A A 801 (-4.7A) A5A A 801 (-3.5A)	1.43A	2hmaA-2ztgA: undetectable	2hmaA-2ztgA: 18.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HMA_A_SAMA375_0 (PROBABLE TRNA (5-METHYLAMINOMETHYL -2-THIOURIDYLATE)-ME THYLTRANSFERASE)	2zzg	ALANYL-TRNA SYNTHETASE (Pyrococcus horikoshii)	5 / 11	GLY A 300 THR A 138 GLY A 139 HIS A 141 PHE A 145	None None None A5A A 999 (-4.8A) A5A A 999 (-3.4A)	1.46A	2hmaA-2zzgA: undetectable	2hmaA-2zzgA: 19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HMA_A_SAMA375_0 (PROBABLE TRNA (5-METHYLAMINOMETHYL -2-THIOURIDYLATE)-ME THYLTRANSFERASE)	3wqy	ALANINE--TRNA LIGASE (Archaeoglobus fulgidus)	5 / 11	GLY A 299 THR A 138 GLY A 139 HIS A 141 PHE A 145	None None None A5A A1001 (-4.2A) A5A A1001 (-3.5A)	1.42A	2hmaA-3wqyA: undetectable	2hmaA-3wqyA: 18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	4 / 8	GLN A 105 ARG A 128 GLY A 194 GLY A 244	None A5A A 801 (-2.7A) None A5A A 801 (-4.0A)	0.82A	2y6rB-2ztgA: undetectable	2y6rB-2ztgA: 20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	2zzg	ALANYL-TRNA SYNTHETASE (Pyrococcus horikoshii)	4 / 8	GLN A 105 ARG A 128 GLY A 195 GLY A 250	None A5A A 999 (-3.0A) None A5A A 999 (-3.5A)	0.63A	2y6rB-2zzgA: undetectable	2y6rB-2zzgA: 20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	3wqy	ALANINE--TRNA LIGASE (Archaeoglobus fulgidus)	4 / 8	GLN A 105 ARG A 128 GLY A 194 GLY A 244	None A5A A1001 (-3.4A) None A5A A1001 (-3.7A)	0.62A	2y6rB-3wqyA: undetectable	2y6rB-3wqyA: 18.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FI0_G_TRPG1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	4 / 8	GLY A 206 ASP A 183 ILE A 184 VAL A 210	None None None A5A A 801 (-4.8A)	0.73A	3fi0G-2ztgA: undetectable	3fi0G-2ztgA: 17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FI0_I_TRPI1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	4 / 8	GLY A 206 ASP A 183 ILE A 184 VAL A 210	None None None A5A A 801 (-4.8A)	0.74A	3fi0I-2ztgA: undetectable	3fi0I-2ztgA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FI0_Q_TRPQ1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	4 / 8	GLY A 206 ASP A 183 ILE A 184 VAL A 210	None None None A5A A 801 (-4.8A)	0.76A	3fi0Q-2ztgA: undetectable	3fi0Q-2ztgA: 17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_B_MIYB2001_1 (TETX2 PROTEIN)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	4 / 8	GLN A 105 ARG A 128 GLY A 194 GLY A 244	None A5A A 801 (-2.7A) None A5A A 801 (-4.0A)	0.65A	3v3nB-2ztgA: undetectable	3v3nB-2ztgA: 19.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_B_MIYB2001_1 (TETX2 PROTEIN)	2zzg	ALANYL-TRNA SYNTHETASE (Pyrococcus horikoshii)	4 / 8	GLN A 105 ARG A 128 GLY A 195 GLY A 250	None A5A A 999 (-3.0A) None A5A A 999 (-3.5A)	0.49A	3v3nB-2zzgA: undetectable	3v3nB-2zzgA: 19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_B_MIYB2001_1 (TETX2 PROTEIN)	3wqy	ALANINE--TRNA LIGASE (Archaeoglobus fulgidus)	4 / 8	GLN A 105 ARG A 128 GLY A 194 GLY A 244	None A5A A1001 (-3.4A) None A5A A1001 (-3.7A)	0.53A	3v3nB-3wqyA: undetectable	3v3nB-3wqyA: 16.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_C_MIYC2001_1 (TETX2 PROTEIN)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	4 / 8	GLN A 105 ARG A 128 GLY A 194 GLY A 244	None A5A A 801 (-2.7A) None A5A A 801 (-4.0A)	0.65A	3v3nC-2ztgA: undetectable	3v3nC-2ztgA: 19.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_C_MIYC2001_1 (TETX2 PROTEIN)	2zzg	ALANYL-TRNA SYNTHETASE (Pyrococcus horikoshii)	4 / 8	GLN A 105 ARG A 128 GLY A 195 GLY A 250	None A5A A 999 (-3.0A) None A5A A 999 (-3.5A)	0.49A	3v3nC-2zzgA: undetectable	3v3nC-2zzgA: 19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_C_MIYC2001_1 (TETX2 PROTEIN)	3wqy	ALANINE--TRNA LIGASE (Archaeoglobus fulgidus)	4 / 8	GLN A 105 ARG A 128 GLY A 194 GLY A 244	None A5A A1001 (-3.4A) None A5A A1001 (-3.7A)	0.52A	3v3nC-3wqyA: undetectable	3v3nC-3wqyA: 16.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WRK_D_CAMD502_0 (CAMPHOR 5-MONOOXYGENASE)	5knn	ALANINE--TRNA LIGASE, CYTOPLASMIC (Homo sapiens)	4 / 5	PHE A 126 LEU A 101 GLY A 243 VAL A 250	None None A5A A 500 (-3.4A) None	1.08A	3wrkD-5knnA: undetectable	3wrkD-5knnA: 20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K87_A_ADNA602_1 (PROLINE--TRNA LIGASE)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	4 / 8	ARG A 128 PHE A 145 THR A 212 ARG A 249	A5A A 801 (-2.7A) A5A A 801 (-3.5A) A5A A 801 (-3.4A) A5A A 801 (-4.0A)	0.53A	4k87A-2ztgA: 8.0	4k87A-2ztgA: 20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K87_A_ADNA602_1 (PROLINE--TRNA LIGASE)	2zzg	ALANYL-TRNA SYNTHETASE (Pyrococcus horikoshii)	4 / 8	ARG A 128 PHE A 145 THR A 213 ARG A 255	A5A A 999 (-3.0A) A5A A 999 (-3.4A) A5A A 999 (-3.1A) A5A A 999 (-3.7A)	0.57A	4k87A-2zzgA: 8.3	4k87A-2zzgA: 22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K87_A_ADNA602_1 (PROLINE--TRNA LIGASE)	3wqy	ALANINE--TRNA LIGASE (Archaeoglobus fulgidus)	4 / 8	ARG A 128 PHE A 145 THR A 212 ARG A 249	A5A A1001 (-3.4A) A5A A1001 (-3.5A) A5A A1001 (-3.5A) A5A A1001 (-3.7A)	0.73A	4k87A-3wqyA: 8.8	4k87A-3wqyA: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KBW_A_RBFA201_1 (RIBOFLAVIN TRANSPORTER RIBU)	5knn	ALANINE--TRNA LIGASE, CYTOPLASMIC (Homo sapiens)	5 / 12	LEU A 39 GLY A 182 ALA A 44 ASN A 47 ASN A 43	None None A5A A 500 (-3.6A) None None	1.06A	5kbwA-5knnA: 3.3	5kbwA-5knnA: 18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O96_G_SAMG501_0 (RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	6 / 11	GLY A 244 LEU A 174 VAL A 167 THR A 212 GLU A 202 ALA A 203	A5A A 801 (-4.0A) None None A5A A 801 (-3.4A) None None	1.48A	5o96G-2ztgA: undetectable	5o96G-2ztgA: 15.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QPA613_1 (SERUM ALBUMIN)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	4 / 8	ARG A 345 SER A 100 THR A 97 GLY A 246	None None None A5A A 801 (-3.3A)	1.00A	5v0vA-2ztgA: 3.3	5v0vA-2ztgA: 23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W7P_A_SAMA501_0 (OXAC)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	5 / 12	ALA A 341 SER A 339 LEU A 142 VAL A 135 ASP A 262	None None A5A A 801 (-4.2A) None None	1.14A	5w7pA-2ztgA: undetectable	5w7pA-2ztgA: 19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AJI_A_AY6A1001_0 (DRUG EXPORTERS OF THE RND SUPERFAMILY-LIKE PROTEIN,ENDOLYSIN)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	5 / 12	ILE A 98 LEU A 129 PHE A 145 ALA A 362 LEU A 365	None None A5A A 801 (-3.5A) None None	1.09A	6ajiA-2ztgA: undetectable	6ajiA-2ztgA: 22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BNI_A_ADNA602_1 (LYSINE--TRNA LIGASE)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	6 / 10	ARG A 128 HIS A 141 PHE A 145 GLU A 209 GLY A 246 ARG A 249	A5A A 801 (-2.7A) A5A A 801 (-4.7A) A5A A 801 (-3.5A) A5A A 801 (-3.7A) A5A A 801 (-3.3A) A5A A 801 (-4.0A)	0.71A	6bniA-2ztgA: 10.8	6bniA-2ztgA: 7.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BNI_A_ADNA602_1 (LYSINE--TRNA LIGASE)	2zzg	ALANYL-TRNA SYNTHETASE (Pyrococcus horikoshii)	6 / 10	ARG A 128 HIS A 141 PHE A 145 GLU A 210 GLY A 252 ARG A 255	A5A A 999 (-3.0A) A5A A 999 (-4.8A) A5A A 999 (-3.4A) A5A A 999 (-3.4A) A5A A 999 (-3.2A) A5A A 999 (-3.7A)	0.77A	6bniA-2zzgA: 10.8	6bniA-2zzgA: 7.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BNI_A_ADNA602_1 (LYSINE--TRNA LIGASE)	3wqy	ALANINE--TRNA LIGASE (Archaeoglobus fulgidus)	5 / 10	ARG A 128 HIS A 141 PHE A 145 GLY A 246 ARG A 249	A5A A1001 (-3.4A) A5A A1001 (-4.2A) A5A A1001 (-3.5A) A5A A1001 (-3.0A) A5A A1001 (-3.7A)	0.77A	6bniA-3wqyA: 11.7	6bniA-3wqyA: 6.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BNI_A_ADNA602_1 (LYSINE--TRNA LIGASE)	3wqy	ALANINE--TRNA LIGASE (Archaeoglobus fulgidus)	5 / 10	HIS A 141 PHE A 145 GLU A 209 GLY A 246 ARG A 249	A5A A1001 (-4.2A) A5A A1001 (-3.5A) A5A A1001 (-3.8A) A5A A1001 (-3.0A) A5A A1001 (-3.7A)	0.68A	6bniA-3wqyA: 11.7	6bniA-3wqyA: 6.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BNI_A_ADNA602_1 (LYSINE--TRNA LIGASE)	5knn	ALANINE--TRNA LIGASE, CYTOPLASMIC (Homo sapiens)	6 / 10	ARG A 77 HIS A 94 PHE A 98 GLU A 213 GLY A 243 ARG A 246	A5A A 500 (-2.8A) A5A A 500 (-4.5A) A5A A 500 (-3.4A) A5A A 500 (-3.8A) A5A A 500 (-3.4A) A5A A 500 (-3.9A)	0.63A	6bniA-5knnA: 11.6	6bniA-5knnA: 12.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BNI_B_ADNB602_1 (LYSINE--TRNA LIGASE)	2ztg	ALANYL-TRNA SYNTHETASE (Archaeoglobus fulgidus)	6 / 10	ARG A 128 HIS A 141 PHE A 145 GLU A 209 GLY A 246 ARG A 249	A5A A 801 (-2.7A) A5A A 801 (-4.7A) A5A A 801 (-3.5A) A5A A 801 (-3.7A) A5A A 801 (-3.3A) A5A A 801 (-4.0A)	0.68A	6bniB-2ztgA: 10.7	6bniB-2ztgA: 7.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BNI_B_ADNB602_1 (LYSINE--TRNA LIGASE)	2zzg	ALANYL-TRNA SYNTHETASE (Pyrococcus horikoshii)	6 / 10	ARG A 128 HIS A 141 PHE A 145 GLU A 210 GLY A 252 ARG A 255	A5A A 999 (-3.0A) A5A A 999 (-4.8A) A5A A 999 (-3.4A) A5A A 999 (-3.4A) A5A A 999 (-3.2A) A5A A 999 (-3.7A)	0.75A	6bniB-2zzgA: 10.8	6bniB-2zzgA: 7.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BNI_B_ADNB602_1 (LYSINE--TRNA LIGASE)	3wqy	ALANINE--TRNA LIGASE (Archaeoglobus fulgidus)	5 / 10	ARG A 128 HIS A 141 PHE A 145 GLY A 246 ARG A 249	A5A A1001 (-3.4A) A5A A1001 (-4.2A) A5A A1001 (-3.5A) A5A A1001 (-3.0A) A5A A1001 (-3.7A)	0.73A	6bniB-3wqyA: 11.3	6bniB-3wqyA: 6.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BNI_B_ADNB602_1 (LYSINE--TRNA LIGASE)	3wqy	ALANINE--TRNA LIGASE (Archaeoglobus fulgidus)	5 / 10	HIS A 141 PHE A 145 GLU A 209 GLY A 246 ARG A 249	A5A A1001 (-4.2A) A5A A1001 (-3.5A) A5A A1001 (-3.8A) A5A A1001 (-3.0A) A5A A1001 (-3.7A)	0.69A	6bniB-3wqyA: 11.3	6bniB-3wqyA: 6.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BNI_B_ADNB602_1 (LYSINE--TRNA LIGASE)	5knn	ALANINE--TRNA LIGASE, CYTOPLASMIC (Homo sapiens)	6 / 10	ARG A 77 HIS A 94 PHE A 98 GLU A 213 GLY A 243 ARG A 246	A5A A 500 (-2.8A) A5A A 500 (-4.5A) A5A A 500 (-3.4A) A5A A 500 (-3.8A) A5A A 500 (-3.4A) A5A A 500 (-3.9A)	0.62A	6bniB-5knnA: 11.8	6bniB-5knnA: 12.47

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["2HMA_A_SAMA375_0","PROBABLE TRNA (5-METHYLAMINOMETHYL-2-THIOURIDYLATE)-METHYLTRANSFERASE","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",5,"GLY A 299;THR A 138;GLY A 139;HIS A 141;PHE A 145","None;None;None;A5A A 801 (-4.7A);A5A A 801 (-3.5A)","1.43A","2hmaA-2ztgA:undetectable",null],["2HMA_A_SAMA375_0","PROBABLE TRNA (5-METHYLAMINOMETHYL-2-THIOURIDYLATE)-METHYLTRANSFERASE","2zzg","ALANYL-TRNA SYNTHETASE","Pyrococcus horikoshii",5,"GLY A 300;THR A 138;GLY A 139;HIS A 141;PHE A 145","None;None;None;A5A A 999 (-4.8A);A5A A 999 (-3.4A)","1.46A","2hmaA-2zzgA:undetectable","2hmaA-2ztgA:18.67"],["2HMA_A_SAMA375_0","PROBABLE TRNA (5-METHYLAMINOMETHYL-2-THIOURIDYLATE)-METHYLTRANSFERASE","3wqy","ALANINE--TRNA LIGASE","Archaeoglobus fulgidus",5,"GLY A 299;THR A 138;GLY A 139;HIS A 141;PHE A 145","None;None;None;A5A A1001 (-4.2A);A5A A1001 (-3.5A)","1.42A","2hmaA-3wqyA:undetectable","2hmaA-2zzgA:19.65"],["2Y6R_B_CTCB1385_0","TETX2 PROTEIN","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",4,"GLN A 105;ARG A 128;GLY A 194;GLY A 244","None;A5A A 801 (-2.7A);None;A5A A 801 (-4.0A)","0.82A","2y6rB-2ztgA:undetectable","2hmaA-3wqyA:18.52"],["2Y6R_B_CTCB1385_0","TETX2 PROTEIN","2zzg","ALANYL-TRNA SYNTHETASE","Pyrococcus horikoshii",4,"GLN A 105;ARG A 128;GLY A 195;GLY A 250","None;A5A A 999 (-3.0A);None;A5A A 999 (-3.5A)","0.63A","2y6rB-2zzgA:undetectable","2y6rB-2ztgA:20.14"],["2Y6R_B_CTCB1385_0","TETX2 PROTEIN","3wqy","ALANINE--TRNA LIGASE","Archaeoglobus fulgidus",4,"GLN A 105;ARG A 128;GLY A 194;GLY A 244","None;A5A A1001 (-3.4A);None;A5A A1001 (-3.7A)","0.62A","2y6rB-3wqyA:undetectable","2y6rB-2zzgA:20.34"],["3FI0_G_TRPG1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",4,"GLY A 206;ASP A 183;ILE A 184;VAL A 210","None;None;None;A5A A 801 (-4.8A)","0.73A","3fi0G-2ztgA:undetectable","2y6rB-3wqyA:18.06"],["3FI0_I_TRPI1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",4,"GLY A 206;ASP A 183;ILE A 184;VAL A 210","None;None;None;A5A A 801 (-4.8A)","0.74A","3fi0I-2ztgA:undetectable","3fi0G-2ztgA:17.50"],["3FI0_Q_TRPQ1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",4,"GLY A 206;ASP A 183;ILE A 184;VAL A 210","None;None;None;A5A A 801 (-4.8A)","0.76A","3fi0Q-2ztgA:undetectable","3fi0I-2ztgA:undetectable"],["3V3N_B_MIYB2001_1","TETX2 PROTEIN","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",4,"GLN A 105;ARG A 128;GLY A 194;GLY A 244","None;A5A A 801 (-2.7A);None;A5A A 801 (-4.0A)","0.65A","3v3nB-2ztgA:undetectable","3fi0Q-2ztgA:17.50"],["3V3N_B_MIYB2001_1","TETX2 PROTEIN","2zzg","ALANYL-TRNA SYNTHETASE","Pyrococcus horikoshii",4,"GLN A 105;ARG A 128;GLY A 195;GLY A 250","None;A5A A 999 (-3.0A);None;A5A A 999 (-3.5A)","0.49A","3v3nB-2zzgA:undetectable","3v3nB-2ztgA:19.45"],["3V3N_B_MIYB2001_1","TETX2 PROTEIN","3wqy","ALANINE--TRNA LIGASE","Archaeoglobus fulgidus",4,"GLN A 105;ARG A 128;GLY A 194;GLY A 244","None;A5A A1001 (-3.4A);None;A5A A1001 (-3.7A)","0.53A","3v3nB-3wqyA:undetectable","3v3nB-2zzgA:19.30"],["3V3N_C_MIYC2001_1","TETX2 PROTEIN","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",4,"GLN A 105;ARG A 128;GLY A 194;GLY A 244","None;A5A A 801 (-2.7A);None;A5A A 801 (-4.0A)","0.65A","3v3nC-2ztgA:undetectable","3v3nB-3wqyA:16.57"],["3V3N_C_MIYC2001_1","TETX2 PROTEIN","2zzg","ALANYL-TRNA SYNTHETASE","Pyrococcus horikoshii",4,"GLN A 105;ARG A 128;GLY A 195;GLY A 250","None;A5A A 999 (-3.0A);None;A5A A 999 (-3.5A)","0.49A","3v3nC-2zzgA:undetectable","3v3nC-2ztgA:19.45"],["3V3N_C_MIYC2001_1","TETX2 PROTEIN","3wqy","ALANINE--TRNA LIGASE","Archaeoglobus fulgidus",4,"GLN A 105;ARG A 128;GLY A 194;GLY A 244","None;A5A A1001 (-3.4A);None;A5A A1001 (-3.7A)","0.52A","3v3nC-3wqyA:undetectable","3v3nC-2zzgA:19.30"],["3WRK_D_CAMD502_0","CAMPHOR 5-MONOOXYGENASE","5knn","ALANINE--TRNA LIGASE, CYTOPLASMIC","Homo sapiens",4,"PHE A 126;LEU A 101;GLY A 243;VAL A 250","None;None;A5A A 500 (-3.4A);None","1.08A","3wrkD-5knnA:undetectable","3v3nC-3wqyA:16.57"],["4K87_A_ADNA602_1","PROLINE--TRNA LIGASE","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",4,"ARG A 128;PHE A 145;THR A 212;ARG A 249","A5A A 801 (-2.7A);A5A A 801 (-3.5A);A5A A 801 (-3.4A);A5A A 801 (-4.0A)","0.53A","4k87A-2ztgA:8.0","3wrkD-5knnA:20.88"],["4K87_A_ADNA602_1","PROLINE--TRNA LIGASE","2zzg","ALANYL-TRNA SYNTHETASE","Pyrococcus horikoshii",4,"ARG A 128;PHE A 145;THR A 213;ARG A 255","A5A A 999 (-3.0A);A5A A 999 (-3.4A);A5A A 999 (-3.1A);A5A A 999 (-3.7A)","0.57A","4k87A-2zzgA:8.3","4k87A-2ztgA:20.89"],["4K87_A_ADNA602_1","PROLINE--TRNA LIGASE","3wqy","ALANINE--TRNA LIGASE","Archaeoglobus fulgidus",4,"ARG A 128;PHE A 145;THR A 212;ARG A 249","A5A A1001 (-3.4A);A5A A1001 (-3.5A);A5A A1001 (-3.5A);A5A A1001 (-3.7A)","0.73A","4k87A-3wqyA:8.8","4k87A-2zzgA:22.11"],["5KBW_A_RBFA201_1","RIBOFLAVIN TRANSPORTER RIBU","5knn","ALANINE--TRNA LIGASE, CYTOPLASMIC","Homo sapiens",5,"LEU A  39;GLY A 182;ALA A  44;ASN A  47;ASN A  43","None;None;A5A A 500 (-3.6A);None;None","1.06A","5kbwA-5knnA:3.3","4k87A-3wqyA:21.12"],["5O96_G_SAMG501_0","RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",6,"GLY A 244;LEU A 174;VAL A 167;THR A 212;GLU A 202;ALA A 203","A5A A 801 (-4.0A);None;None;A5A A 801 (-3.4A);None;None","1.48A","5o96G-2ztgA:undetectable","5kbwA-5knnA:18.83"],["5V0V_A_8QPA613_1","SERUM ALBUMIN","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",4,"ARG A 345;SER A 100;THR A  97;GLY A 246","None;None;None;A5A A 801 (-3.3A)","1.00A","5v0vA-2ztgA:3.3","5o96G-2ztgA:15.06"],["5W7P_A_SAMA501_0","OXAC","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",5,"ALA A 341;SER A 339;LEU A 142;VAL A 135;ASP A 262","None;None;A5A A 801 (-4.2A);None;None","1.14A","5w7pA-2ztgA:undetectable","5v0vA-2ztgA:23.10"],["6AJI_A_AY6A1001_0","DRUG EXPORTERS OF THE RND SUPERFAMILY-LIKE PROTEIN,ENDOLYSIN","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",5,"ILE A  98;LEU A 129;PHE A 145;ALA A 362;LEU A 365","None;None;A5A A 801 (-3.5A);None;None","1.09A","6ajiA-2ztgA:undetectable","5w7pA-2ztgA:19.49"],["6BNI_A_ADNA602_1","LYSINE--TRNA LIGASE","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",6,"ARG A 128;HIS A 141;PHE A 145;GLU A 209;GLY A 246;ARG A 249","A5A A 801 (-2.7A);A5A A 801 (-4.7A);A5A A 801 (-3.5A);A5A A 801 (-3.7A);A5A A 801 (-3.3A);A5A A 801 (-4.0A)","0.71A","6bniA-2ztgA:10.8","6ajiA-2ztgA:22.33"],["6BNI_A_ADNA602_1","LYSINE--TRNA LIGASE","2zzg","ALANYL-TRNA SYNTHETASE","Pyrococcus horikoshii",6,"ARG A 128;HIS A 141;PHE A 145;GLU A 210;GLY A 252;ARG A 255","A5A A 999 (-3.0A);A5A A 999 (-4.8A);A5A A 999 (-3.4A);A5A A 999 (-3.4A);A5A A 999 (-3.2A);A5A A 999 (-3.7A)","0.77A","6bniA-2zzgA:10.8","6bniA-2ztgA:7.22"],["6BNI_A_ADNA602_1","LYSINE--TRNA LIGASE","3wqy","ALANINE--TRNA LIGASE","Archaeoglobus fulgidus",5,"ARG A 128;HIS A 141;PHE A 145;GLY A 246;ARG A 249","A5A A1001 (-3.4A);A5A A1001 (-4.2A);A5A A1001 (-3.5A);A5A A1001 (-3.0A);A5A A1001 (-3.7A)","0.77A","6bniA-3wqyA:11.7","6bniA-2zzgA:7.07"],["6BNI_A_ADNA602_1","LYSINE--TRNA LIGASE","3wqy","ALANINE--TRNA LIGASE","Archaeoglobus fulgidus",5,"HIS A 141;PHE A 145;GLU A 209;GLY A 246;ARG A 249","A5A A1001 (-4.2A);A5A A1001 (-3.5A);A5A A1001 (-3.8A);A5A A1001 (-3.0A);A5A A1001 (-3.7A)","0.68A","6bniA-3wqyA:11.7","6bniA-3wqyA:6.21"],["6BNI_A_ADNA602_1","LYSINE--TRNA LIGASE","5knn","ALANINE--TRNA LIGASE, CYTOPLASMIC","Homo sapiens",6,"ARG A  77;HIS A  94;PHE A  98;GLU A 213;GLY A 243;ARG A 246","A5A A 500 (-2.8A);A5A A 500 (-4.5A);A5A A 500 (-3.4A);A5A A 500 (-3.8A);A5A A 500 (-3.4A);A5A A 500 (-3.9A)","0.63A","6bniA-5knnA:11.6","6bniA-3wqyA:6.21"],["6BNI_B_ADNB602_1","LYSINE--TRNA LIGASE","2ztg","ALANYL-TRNA SYNTHETASE","Archaeoglobus fulgidus",6,"ARG A 128;HIS A 141;PHE A 145;GLU A 209;GLY A 246;ARG A 249","A5A A 801 (-2.7A);A5A A 801 (-4.7A);A5A A 801 (-3.5A);A5A A 801 (-3.7A);A5A A 801 (-3.3A);A5A A 801 (-4.0A)","0.68A","6bniB-2ztgA:10.7","6bniA-5knnA:12.47"],["6BNI_B_ADNB602_1","LYSINE--TRNA LIGASE","2zzg","ALANYL-TRNA SYNTHETASE","Pyrococcus horikoshii",6,"ARG A 128;HIS A 141;PHE A 145;GLU A 210;GLY A 252;ARG A 255","A5A A 999 (-3.0A);A5A A 999 (-4.8A);A5A A 999 (-3.4A);A5A A 999 (-3.4A);A5A A 999 (-3.2A);A5A A 999 (-3.7A)","0.75A","6bniB-2zzgA:10.8","6bniB-2ztgA:7.22"],["6BNI_B_ADNB602_1","LYSINE--TRNA LIGASE","3wqy","ALANINE--TRNA LIGASE","Archaeoglobus fulgidus",5,"ARG A 128;HIS A 141;PHE A 145;GLY A 246;ARG A 249","A5A A1001 (-3.4A);A5A A1001 (-4.2A);A5A A1001 (-3.5A);A5A A1001 (-3.0A);A5A A1001 (-3.7A)","0.73A","6bniB-3wqyA:11.3","6bniB-2zzgA:7.07"],["6BNI_B_ADNB602_1","LYSINE--TRNA LIGASE","3wqy","ALANINE--TRNA LIGASE","Archaeoglobus fulgidus",5,"HIS A 141;PHE A 145;GLU A 209;GLY A 246;ARG A 249","A5A A1001 (-4.2A);A5A A1001 (-3.5A);A5A A1001 (-3.8A);A5A A1001 (-3.0A);A5A A1001 (-3.7A)","0.69A","6bniB-3wqyA:11.3","6bniB-3wqyA:6.21"],["6BNI_B_ADNB602_1","LYSINE--TRNA LIGASE","5knn","ALANINE--TRNA LIGASE, CYTOPLASMIC","Homo sapiens",6,"ARG A  77;HIS A  94;PHE A  98;GLU A 213;GLY A 243;ARG A 246","A5A A 500 (-2.8A);A5A A 500 (-4.5A);A5A A 500 (-3.4A);A5A A 500 (-3.8A);A5A A 500 (-3.4A);A5A A 500 (-3.9A)","0.62A","6bniB-5knnA:11.8","6bniB-3wqyA:6.21"]]